Limiting portfolio volatility should be part of
every investors risk management plan.
Not exact matches
Such
risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational
plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of
management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific
risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the
Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the
Investor Relations section of www.express-scripts.com.
Ryan Labs Asset
Management Inc. (Ryan Labs), a Sun Life Investment
Management company, has announced the launch of their Defensive
Risk Premia (DRP) strategy for corporate and public pension
plans, as well as other institutional
investors.
Every value
investor should have a
risk management plan that includes these concepts:
If you are interested in delving deeper into the subject, read my
risk management plan for value
investors post.
Value
investors need a
risk management plan that prevents a permanent loss of capital through the use of asset allocation, diversification, and valuation investing.
NEW YORK, Feb. 27, 2018 / PRNewswire / - Ryan Labs Asset
Management Inc. (Ryan Labs), a Sun Life Investment
Management company, today announced the launch of their Defensive
Risk Premia (DRP) strategy for corporate and public pension
plans, as well as other institutional
investors.
Mark Campanale, Carbon Tracker Founder and Executive Director, said: «These disclosure principles go to the very core of the energy transition that is underway — they show
investors and markets the extent to which individual fossil fuel companies may be at
risk, as well as
management's
plans for addressing the looming issue.
Glenn will oversee the
planning,
risk management,
investor relations and budgeting functions.